Dr. Jyoti Malhotra is a thoracic medical oncologist specializing in lung cancer and early-phase clinical trials. Her work focuses on precision medicine, immunotherapy, and the development of novel cancer therapeutics, with extensive leadership in investigator-initiated and first-in-human studies.
Current Position
- Interim Division Chief, Thoracic Medical Oncology, City of Hope, Duarte, USA
- Director, Thoracic Medical Oncology, City of Hope Orange County, USA
- Associate Professor, Department of Medical Oncology & Therapeutics Research, City of Hope
Education
- MPH, Johns Hopkins Bloomberg School of Public Health (2006)
- MD (MBBS), University of Delhi (2005)
- Residency in Internal Medicine, Georgetown University Hospital / Washington Hospital Center
- Fellowship in Hematology & Oncology, Icahn School of Medicine at Mount Sinai (2012–2015)
Area of Specialization
- Thoracic oncology
- Lung cancer and mesothelioma
- Early-phase (Phase I) clinical trials
- Precision medicine
- Immunotherapy
Professional Experience
- Associate Professor, Robert Wood Johnson Medical School
- Attending Physician, Rutgers Cancer Institute of New Jersey
- Instructor, Memorial Sloan Kettering Cancer Center
Research & Clinical Activity
- Leader in early-phase and experimental therapeutics programs
- Institutional principal investigator on 50+ clinical trials
- Led 10+ investigator-initiated trials, including first-in-human studies
- Research in immunotherapy resistance and biomarker-driven therapies
Publications
- Author of 100+ peer-reviewed publications in oncology
- Contributions to lung cancer genomics, immunotherapy, and clinical trial development
Leadership & Memberships
- Contributor to NCCN Clinical Practice Guidelines (Small Cell Lung Cancer)
- Member, American Society of Clinical Oncology (ASCO)
- Member, American Association for Cancer Research (AACR)
- Member, International Association for the Study of Lung Cancer (IASLC)
All information is sourced from publicly available materials.